Pohjola Bank PLC Ratings Affirmed At 'AA-/A-1+' On Bank Criteria Change; Outlook Stable Dec 11

  • ID: 2029642
  • December 2011
  • Standard & Poors
1 of 3

Following a review under Standard & Poor's revised bank criteria (published Nov. 9, 2011), we have affirmed our 'AA-' long-term and 'A-1+' short-term counterparty credit ratings on Pohjola Bank PLC. The outlook is stable. The ratings reflect the bank's strong business position, strong capital and earnings, adequate risk position, average funding, and adequate liquidity. We consider Pohjola Bank to have high systemic importance in Finland, which we classify as supportive, and accordingly add one notch of uplift above the bank's stand-alone credit profile. The ratings are not directly affected by our recent decision to place the Republic of Finland on Creditwatch with negative implications. The stable outlook reflects our view that Pohjola Bank will comfortably keep its risk-adjusted capital ratio...

Companies mentioned in this report are:
- Pohjola Bank PLC
- Pohjola Non-Life Insurance Co. Ltd.

Action: Affirmed

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research type: News
This product is a is a brief one-page announcement of no more than 500 words with a quote from the analyst. It is media and investor focused with no accompanying commentary article.

Note: Product cover images may vary from those shown
2 of 3

- Pohjola Bank PLC
- Pohjola Non-Life Insurance Co. Ltd.

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown




Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.